HOFSETH BIOCARE ASA: NOTICE OF EXTRAORDINARY GENERAL MEETING
Reference is made to the stock exchange announcements by Hofseth BioCare ASA ("HBC" or the "Company") on 28 and 29 June 2026 regarding completion of delivery of Offer Shares in tranche 2 (the "T2 Offer Shares") where its subject to an extraordinary general meeting (the "EGM") resolving to inter alia, (i) issue the T2 Offer Shares in the Private Placement and (ii) amend the terms of the Company’s B-shares ("B-Shares Amendments").
Reference is made to the stock exchange announcements by Hofseth BioCare ASA ("HBC" or the "Company") on 28 and 29 June 2026 regarding completion of delivery of Offer Shares in tranche 2 (the "T2 Offer Shares") where its subject to an extraordinary general meeting (the "EGM") resolving to inter alia, (i) issue the T2 Offer Shares in the Private Placement and (ii) amend the terms of the Company’s B-shares ("B-Shares Amendments").
Summary aggregated from GlobeNewswire's public RSS feed. The full reporting belongs to GlobeNewswire — please read it on their site.